LGD-4033, also called Ligandrol, is not approved by any regulatory agency for human use, and the limited clinical data that exists raises real safety concerns. The FDA has explicitly warned consumers against using it, citing risks including liver injury, cardiovascular problems, hormonal disruption, and infertility. Here’s what the actual evidence shows.
What LGD-4033 Does in the Body
LGD-4033 belongs to a class of compounds called selective androgen receptor modulators, or SARMs. It binds to the same receptors that testosterone does, primarily in muscle and bone tissue, which is why it’s marketed in fitness circles as a way to build lean mass without the broader side effects of anabolic steroids. The “selective” part of the name suggests it targets only certain tissues, but the clinical reality is messier than the marketing implies.
Even in the only published Phase 1 human trial, conducted with healthy young men taking the drug for just 21 days, LGD-4033 suppressed the body’s own testosterone production, lowered HDL (“good”) cholesterol, and reduced sex hormone-binding globulin in a dose-dependent pattern. The higher the dose, the worse the suppression. At the 1.0 mg dose, both free testosterone and follicle-stimulating hormone (a key hormone for fertility) were significantly suppressed. These aren’t minor lab fluctuations. They represent meaningful hormonal disruption from a short exposure at doses far below what most recreational users take.
Hormonal Suppression and Recovery
One of the most common claims about LGD-4033 is that it’s “mild” compared to steroids and that your hormones bounce back quickly. The Phase 1 trial did show that testosterone levels returned to baseline by day 56 after stopping the drug. That sounds reassuring until you consider the context: participants took the compound for only 21 days at doses of 0.1 mg, 0.3 mg, or 1.0 mg.
Recreational users commonly take 5 to 10 mg per day for 8 to 12 weeks. No controlled study has measured what happens to hormonal recovery at those doses and durations. The suppression seen in the trial was dose-dependent, meaning it got worse with each step up. Extrapolating from 1.0 mg over 21 days to 10 mg over 12 weeks is not a small leap, and recovery timelines could be significantly longer or less predictable.
Liver Damage Is a Real Risk
The most alarming documented harm from LGD-4033 is liver injury. A case report published in the journal Cureus described a patient who developed jaundice, severe itching, and significant weight loss after three months of high-dose use. On admission, liver enzyme levels were dramatically elevated: ALT was more than four times the upper limit of normal, and total bilirubin reached 17 mg/dL, well into the range that turns skin and eyes yellow. The combination of jaundice with ALT levels that high is considered a warning sign for potential liver failure, serious enough that the patient was referred for hepatology follow-up and monitored for possible transplant need.
The patient’s liver enzymes did begin to improve after stopping the drug, dropping over the following three months, but they were still above normal range even at the three-month follow-up. This wasn’t a case of someone with pre-existing liver disease. It was a healthy adult using a product marketed as safer than steroids.
Cardiovascular Concerns
LGD-4033 lowered HDL cholesterol in the Phase 1 trial, and this effect was dose-dependent. HDL is the type of cholesterol that helps clear fat from your arteries. Suppressing it raises cardiovascular risk over time, particularly if someone is running repeated cycles. The FDA’s warning on SARMs specifically lists increased risk of heart attack and stroke among potential dangers. No long-term cardiovascular data exists for LGD-4033 in humans, which means anyone using it is running an uncontrolled experiment on their own heart health.
No Long-Term Safety Data Exists
This is the most important point for anyone weighing the risks. The entire body of controlled human evidence for LGD-4033 comes from a single 21-day trial in 76 healthy men. That’s it. There are no 6-month studies. No 1-year studies. No data on what happens after multiple cycles. No data on effects in women. No data on interactions with other supplements or drugs commonly stacked alongside it.
Everything beyond that single trial is case reports of people who were harmed and anecdotal reports from online forums. The absence of long-term data doesn’t mean the drug is safe. It means nobody has systematically checked.
What You’re Actually Buying
Even if LGD-4033 had a favorable safety profile (it doesn’t), there’s a separate problem: the products on the market are unreliable. A JAMA analysis of 44 products sold online as SARMs found that only 41% actually contained the compound and dose listed on the label. Some contained different SARMs than advertised. Some contained no active compound at all. Others contained unapproved drugs or unlisted ingredients.
Because SARMs cannot be legally sold as dietary supplements or drugs in the United States, the products available online exist in a regulatory gray zone with no quality control, no standardized manufacturing, and no accountability. You have no reliable way to know what’s in the bottle, how much of it is there, or what contaminants it might contain.
Legal and Regulatory Status
The FDA considers LGD-4033 an unapproved drug. It cannot be legally marketed as a dietary supplement in the U.S., and the agency has issued a public warning specifically targeting SARMs use among teens and young adults. The warning lists liver injury, acute liver failure, infertility, testicular shrinkage, psychosis, sleep disturbances, and sexual dysfunction among the associated risks.
LGD-4033 is also banned by the World Anti-Doping Agency. It appears on the 2025 Prohibited List under “Other Anabolic Agents,” alongside other SARMs like ostarine and RAD140. It is prohibited at all times, both in and out of competition. Athletes who test positive face sanctions regardless of whether they intended to take it, and cross-contamination from poorly labeled supplements has ended careers.
The Gap Between Marketing and Evidence
LGD-4033 is sold with the implication that it offers steroid-like muscle gains with fewer side effects. The clinical evidence tells a different story. Even at tiny doses for short periods, it suppresses your natural testosterone, lowers protective cholesterol, and disrupts reproductive hormones. At the doses people actually use, it has caused serious liver damage. No regulatory body anywhere in the world has approved it for any purpose, and the products available are frequently mislabeled or contaminated.
The honest answer to whether LGD-4033 is safe: there is no dose, duration, or source that has been established as safe for human use. The short-term risks are documented. The long-term risks are completely unknown.